Go to
JCI Insight
Citations to this article
L. Darryl Quarles
Published January 9, 2013
Citation Information: J Clin Invest. 2013;123(2):542-543. https://doi.org/10.1172/JCI67203.
Citation Information: J Clin Invest. 2013;123(2):542-543. https://doi.org/10.1172/JCI67203.
Abstract
Clinical vignette: A 48-year-old man with chronic kidney disease stage five due to type II diabetes mellitus and hypertension was referred for hemodialysis initiation. His physical exam showed a blood pressure of 150/80, normal fundi, a positive fourth heart sound (S4), and trace pedal edema. Moderate aortic calcification was present on prior chest X-ray. The ECG showed left ventricle hypertrophy by voltage and slight prolongation of the QT interval. Medications included chlorthalidone, amlodipine, carvedilol, cholecalciferol, erythropoietin, and a phosphate binder. What additional therapy should be initiated to reduce vascular calcifications and cardiovascular mortality?
Authors
L. Darryl Quarles
Citation information
Citations to this article (5)
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)